Role of P-glycoprotein in distribution of nelfinavir across the blood-mammary tissue barrier and blood-brain barrier

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1626-1628

  Edwards, Jeffrey E ^a   Alcorn, Jane ^b   Savolainen, Juoko ^c   Anderson, Bradley D ^d   McNamara, Patrick J ^d,e  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF KENTUCKY   (United States)

^e University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELACRIDAR; GLYCOPROTEIN P; NELFINAVIR; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD MAMMARY TISSUE BARRIER; BRAIN; BREAST; BREAST FEEDING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; LACTATION; MILK; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ACRIDINES; ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; FEMALE; HIV PROTEASE INHIBITORS; LACTATION; MAMMARY GLANDS, ANIMAL; MILK; NELFINAVIR; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES;

EID: 16244417452     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1626-1628.2005     Document Type: Article

References (11)

1. Alcorn, J., X. Lu, J. A. Moscow, and P. J. McNamara. 2002. Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction. J. Pharmacol. Exp. Ther. 303:487-496.
2. Choo, E. F., B. Leake, C. Wandel, H. Imamura, A. J. Wood, G. R. Wilkinson, and R. B. Kim. 2000. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab. Dispos. 28:655-660.
3. Flexner, C. 1998. HIV-protease inhibitors. N. Engl. J. Med. 338:1281-1292.
4. Fowler, M. G., and M. L. Newell. 2002. Breast-feeding and HIV-1 transmission in resource-limited settings. J. Acquir. Immune Defic. Syndr. 30:230-239.
5. Hyafil, F., C. Vergely, P. Du Vignaud, and T. Grand-Perret. 1993. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53:4595-4602.
6. Longer, M., B. Shetty, I. Zamansky, and P. Tyle. 1995. Preformulation studies of a novel HIV protease inhibitor, AG1343. J. Pharm. Sci. 84:1090-1093.
7. Lowry, O. H., N. J. Rosebrough, and, R. J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
8. Morgan, M. E., S. C. Chi, K. Murakami, H. Mitsuya, and B. D. Anderson. 1992. Central nervous system targeting of 2′,3′-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs. Antimicrob. Agents Chemother. 36:2156-2165.
9. Moyle, G. J., M. Youle, C. Higgs, J. Monaghan, W. Prince, S. Chapman, N. Clendeninn, and M. R. Nelson. 1998. Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus. J. Clin. Pharmacol. 38:736-743.
10. Rana, K. Z., and M. N. Dudley. 1999. Human immunodeficiency virus protease inhibitors. Pharmacotherapy 19:35-59.
11. Savolainen, J., J. E. Edwards, M. E. Morgan, P. J. McNamara, and B. D. Anderson. 2002. Effects of a P-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administered in combination in rats. Drug Metab. Dispos. 30:479-482.